arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

Prestige Consumer Healthcare Inc.

PBH
$54.87 ▲ +0.50 (+0.92%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
66 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Bullish
auto_awesome

Analytical Summary

Prestige Consumer Healthcare Inc. shows strong fundamentals with top-quartile Profit Margin (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth -5.0%
Op. Margin 26.8%
ROIC 2.1%
FCF / Share None
Trailing P/E 48.6x
Price / Book
FCF Yield
Debt / Equity 0.53
info Valuation on last close. End-of-day price, Aug 7, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$281.62M
↓ -5.0%
Net Income Profit after all expenses
$53.93M
↑ +7.6%
Operating Margin Operating profit as % of sales
26.8%
↓ -7.9% 93th
FCF / Share Free cash flow per share
$1.57
↑ +39.1%
Long-Term Debt Long-term obligations
$993.95M
↓ -3.8%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
87
Returns
63
Financial Health
58
Cash Quality
71

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 66 quarters